Another Trial Finds Famotidine Aids Hospitalized COVID Patients Another Trial Finds Famotidine Aids Hospitalized COVID Patients
An observational study of 83 hospitalized patients found that famotidine helped reduce in-hospital mortality and intubation. It also demonstrated lower levels of serum markers for severe disease.Medscape Medical News (Source: Medscape Critical Care Headlines)
Source: Medscape Critical Care Headlines - August 25, 2020 Category: Intensive Care Tags: Infectious Diseases News Source Type: news

Study claims patients taking Pepcid AC are more likely to survive COVID-19
Hartford Hospital in Connecticut has found that famotidine might help patients avoid mechanical ventilation and even improve the odds that they survive coronavirus - but the drug is controversial. (Source: the Mail online | Health)
Source: the Mail online | Health - August 19, 2020 Category: Consumer Health News Source Type: news

Popular Heartburn Drugs Linked to Heightened COVID-19 Risk
A popular form of heartburn medication may increase a person’s risk of developing COVID-19, according to a new study, lengthening the already long list of risk factors for the virus. In the study, published Tuesday in pre-print form in the American Journal of Gastroenterology, scientists led by Cedars-Sinai Medical Center’s Dr. Brennan Spiegel conducted an online survey involving more than 86,000 people. Among them, more than 53,000 reported abdominal pain or discomfort, acid reflux, heartburn or regurgitation, and answered questions about the medications they took to relieve those symptoms. Of those, more than...
Source: TIME: Health - July 7, 2020 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized COVID-19 Source Type: news

The Week That Wasn't: Famotidine, Hospital Spread, Mask Markup The Week That Wasn't: Famotidine, Hospital Spread, Mask Markup
Three medical stories that we didn't cover, explained.Medscape (Source: Medscape Infectious Diseases Headlines)
Source: Medscape Infectious Diseases Headlines - June 12, 2020 Category: Infectious Diseases Tags: Infectious Diseases News Source Type: news

Could Heartburn Med Pepcid Ease COVID-19 Symptoms?
Famotidine, sold under the brand name Pepcid, appeared to improve symptoms in a group of 10 patients diagnosed with COVID-19, researchers reported online June 4 in the journal Gut. (Source: WebMD Health)
Source: WebMD Health - June 5, 2020 Category: Consumer Health News Source Type: news

Some COVID-19 Outpatients Say Famotidine Eased Symptoms
FRIDAY, June 5, 2020 -- A small number of nonhospitalized patients with COVID-19 who self-medicated with high-dose famotidine reported some relief of their symptoms, according to a case series published online June 4 in Gut. Tobias Janowitz, M.D.,... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - June 5, 2020 Category: Pharmaceuticals Source Type: news

Could Heartburn Med Pepcid Ease COVID-19 Symptoms?
THURSDAY, June 4, 2020 -- An over-the-counter heartburn remedy is showing some potential as a symptom reliever for COVID-19, a small study finds. Famotidine, sold under the brand name Pepcid, appeared to improve symptoms in a group of 10 patients... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - June 4, 2020 Category: General Medicine Source Type: news

Applying symptom tracking to COVID-19 outpatient care using famotidine
(Cold Spring Harbor Laboratory) Researchers are developing methods to test COVID-19 treatments on non-hospitalized patients. The Northwell-CSHL team of clinicians/researchers used famotidine as a proof-of-concept that outpatient symptom tracking may accelerate prioritization of effective drug regimens to be pursued more rigorously in clinical trials. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - June 4, 2020 Category: Infectious Diseases Source Type: news

Study shows Covid-19 patients who took heartburn drug were less likely to die, but researchers caution more research is needed
Patients who took a common heartburn medicine while hospitalized for Covid-19 were more than twice as likely to survive the infection, according to a paper posted Friday on a pre-publication website. But it's unclear whether the patients fared better because of the famotidine or if it was a coincidence. (Source: CNN.com - Health)
Source: CNN.com - Health - May 10, 2020 Category: Consumer Health News Source Type: news

Researchers studying a common heartburn drug as treatment for Covid-19
Hospitals in New York are giving Covid-19 patients the heartburn medicine famotidine to see if it helps fight the virus, according to the doctor who initiated the trial. (Source: CNN.com - Health)
Source: CNN.com - Health - April 27, 2020 Category: Consumer Health News Source Type: news

FDA Calls For Heartburn Drug Zantac To Be Pulled From Market Immediately
(CNN) — The US Food and Drug Administration is requesting that manufacturers pull all prescription and over-the-counter ranitidine drugs, known by the brand name Zantac, from the market immediately, the agency announced on Wednesday. The FDA noted that an ongoing investigation has determined that levels of a contaminant in the heartburn medications increase over time and when stored at higher-than-normal temperatures, poses a risk to public health. The contaminant, N-nitrosodimethylamine or NDMA, is a probable human carcinogen and the FDA has been investigating levels of it in ranitidine since the summer of 2019. &ld...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - April 1, 2020 Category: Consumer Health News Authors: Health – CBS Boston Tags: Health News Syndicated CBSN Boston CNN Zantac Source Type: news

Medicine Supply Notifications - Clonidine and H2-antagonists (cimetidine, famotidine and nizatidine)
The Department of Health and Social Care (DHSC) has issued the following Medicine Supply Notifications: (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - December 23, 2019 Category: Drugs & Pharmacology Source Type: news

PPI, H2RA Equally Good at Preventing Bleeding Recurrence in H. Pylori-Negative Ulcers PPI, H2RA Equally Good at Preventing Bleeding Recurrence in H. Pylori-Negative Ulcers
Lansoprazole and famotidine have comparable effects in preventing recurrent idiopathic gastroduodenal ulcer bleeding, a two-year randomized clinical trial shows.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - July 12, 2019 Category: Consumer Health News Tags: Medscape Today News Source Type: news

famotidine (Pepcid AC)
Title: famotidine (Pepcid AC)Category: MedicationsCreated: 12/31/1997 12:00:00 AMLast Editorial Review: 3/6/2019 12:00:00 AM (Source: MedicineNet Digestion General)
Source: MedicineNet Digestion General - March 6, 2019 Category: Nutrition Source Type: news

Dr Reddy's Lab recalls Famotidine tablets from US market
As many as 5,69,376 bottles of Famotidine tablets, 10 mg belonging to multiple lots packaged in 30-count, are being recalled nationwide. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - October 20, 2017 Category: Pharmaceuticals Source Type: news

Famotidine Injection (Famotidine Injection) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - November 30, 2016 Category: Drugs & Pharmacology Source Type: news

Pepcid (Famotidine) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - November 30, 2016 Category: Drugs & Pharmacology Source Type: news

Pepcid Injection (Famotidine Injection) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - November 30, 2016 Category: Drugs & Pharmacology Source Type: news

This Popular Kind Of Heartburn Medicine Can Increase Stroke Risk
This study further questions the cardiovascular safety of these drugs,” Sehested said. Although the study found an association between PPIs and stroke risk, it does not prove cause and effect. More studies are needed, and doctors should consider if and for how long patients should take these drugs, the researchers said. [7 Bizarre Drug Side Effects] PPIs are not the only medicines available to treat heartburn. The researchers noted that another type of heartburn medication, called a histamine H2 antagonist, was found to have no association with stroke risk in the study. Histamine H2 antagonists include famotidine (Pe...
Source: Science - The Huffington Post - November 21, 2016 Category: Science Source Type: news

famotidine, Pepcid, Pepcid AC
Title: famotidine, Pepcid, Pepcid ACCategory: MedicationsCreated: 12/31/1997 12:00:00 AMLast Editorial Review: 6/30/2016 12:00:00 AM (Source: MedicineNet Medications General)
Source: MedicineNet Medications General - June 30, 2016 Category: Drugs & Pharmacology Source Type: news

Duexis (Ibuprofen and Famotidine Tablets) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - May 23, 2016 Category: Drugs & Pharmacology Source Type: news

Aurobindo Pharma gets USFDA nod for acid reflux treatment drug
Aurobindo Pharma has received final approval from the US health regulator to manufacture and market Famotidine Tablets used for acid reflux treatment. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - December 24, 2015 Category: Pharmaceuticals Source Type: news

Taking Certain Heartburn Meds Linked To Higher Risk Of Heart Attack
By Kathryn Doyle (Reuters Health) - People who take certain popular heartburn medications, like omeprazole (Prilosec), are at increased risk of heart attack, according to a data mining study by U.S. researchers. The drugs, called proton-pump inhibitors (PPIs), lower acidity in the stomach and prevent the burning sensation in the esophagus that indicates acid reflux. There have been questions about the safety of these drugs for people who have had a coronary event like a heart attack, said lead author Nigam H. Shah of Stanford University in California, but most research has focused on the interaction be...
Source: Science - The Huffington Post - June 10, 2015 Category: Science Source Type: news

Daily low-dose aspirin can prevent heart attack and stroke but is often misused
Aspirin is often hailed as a wonder drug, thanks to its ability to help stave off heart attacks and clot-caused strokes. But fewer than half of people who could benefit from a daily low-dose aspirin take it, while many others take it when they shouldn't, reports the January 2014 Harvard Heart Letter. If you don't have heart disease, but do have high blood pressure, diabetes, or other risk factors for heart disease, don't automatically assume that taking aspirin every day is a good idea. "A lot of people take aspirin who really shouldn't," says Dr. Christopher Cannon, a cardiologist at Brigham and Women's Hospital...
Source: New Harvard Health Information - December 20, 2013 Category: Consumer Health News Source Type: news

Antihistamine May Decrease Schizophrenia SymptomsAntihistamine May Decrease Schizophrenia Symptoms
The histamine H2-receptor antagonist famotidine decreased symptom scores by 10% in patients with treatment-resistant schizophrenia, according to a small, randomized controlled trial. Medscape Medical News (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - October 9, 2013 Category: Consumer Health News Tags: Psychiatry News Source Type: news

Horizon Pharma Announces Settlement of DUEXIS(R) Patent Litigation With Par Pharmaceutical
DEERFIELD, IL--(Healthcare Sales & Marketing Network) - Horizon Pharma, Inc. (NASDAQ: HZNP) today announced that it has entered into settlement and license agreements with Par Pharmaceutical Companies, Inc. and its subsidiary Par Pharmaceutical, Inc., to r... Biopharmaceuticals, Generics, Litigation, LicensingHorizon Pharma, Par Pharmaceutical, DUEXIS, ibuprofen, famotidine (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - August 22, 2013 Category: Pharmaceuticals Source Type: news

Famotidine Blocks Histamine H2 Receptor, Offering New Treatment For Schizophrenia
A research group led by professor Jesper Ekelund showed that by giving a very large dose of famotidine (200 mg daily), sufficient amounts of the drug are able to penetrate the so-called blood-brain barrier to affect the histamine system in the brain. Famotidine has been used for the treatment of heartburn since the 1980s, but at regular dosing, famotidine almost does not enter the brain at all, since the brain is protected by the blood-brain barrier. By increasing the dosage five-fold the drug is able to enter the brain and affect the histamine system... (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - July 3, 2013 Category: Consumer Health News Tags: Schizophrenia Source Type: news

New treatment for schizophrenia discovered in Finland
(University of Helsinki) A study at the University of Helsinki has revealed that a drug called famotidine can decrease the symptoms of persons suffering from schizophrenia. The research shows that the histamine system in the brain could have a central role in the treatment of psychosis, and could lead to the development of a new class of psychosis medications. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - July 1, 2013 Category: Global & Universal Source Type: news

Duexis (Ibuprofen and Famotidine Tablets) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - January 31, 2013 Category: Drugs & Pharmacology Source Type: news